Genome-wide association study of glucocerebrosidase activity modifiers

Area of Science:

• Genetics
• Neuroscience
• Biochemistry

Background:

• Genetic variants in GBA1, encoding glucocerebrosidase (GCase), are significant risk factors for Parkinson's disease (PD).
• GCase deficiency is linked to increased PD risk, but other genetic modifiers likely influence GCase activity.
• Understanding these modifiers is crucial for comprehending PD pathogenesis.

Purpose of the Study:

• To identify common genetic variants associated with GCase activity.
• To replicate known associations between GBA1 variants and GCase activity.
• To explore potential interactions influencing GCase activity in PD.

Main Methods:

• Genome-wide association study (GWAS) conducted on two independent cohorts (Columbia University and PPMI).
• Analysis included PD cases and controls.
• Interaction analyses were performed to investigate gene-gene effects.

Main Results:

• GBA1 variants, particularly p.N370S, showed the strongest association with decreased GCase activity.
• A novel association was identified in the GAA locus, potentially indicating an interaction with acid alpha-glucosidase.
• Several PD-risk loci were found to be potentially associated with GCase activity.

Conclusions:

• GBA1 variants are key determinants of GCase activity in PD.
• The GAA locus represents a novel genetic factor potentially interacting with GCase.
• Further research is needed to validate these findings and elucidate the functional relationship between acid alpha-glucosidase and GCase in PD.